National Institutes of Health: Health nformaton: The Kidneys and How They Work
In the Redox Biology study described earlier [5], individuals with type 2 diabetes treated with GLP-1 receptor agonists demonstrated reduced ROS production, restoration of mitochondrial membrane potential, improved oxygen consumption, and lower levels of myeloperoxidase (MPO)
AOD 9604 clinical trials showed a tolerability profile statistically indistinguishable from placebo
Place stronger human or clinical-context evidence toward the top and preclinical or regulatory-safety context below
Agerso H, Jensen LB, Elbrond B, Rolan P, Zdravkovic M
Evidence indicates that when used alongside a balanced diet, physical activity, and clinical support, Wegovy users taking Wegovy 7.2mg lost an average of 20.7% of their body weight over 72 weeks